Stock listing

NASDAQ:MGX Metagenomi Therapeutics, Inc. Stock

Home listing (NASDAQ) of Metagenomi Therapeutics, Inc.

Follow Metagenomi Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:MGX

$0.812 USD +0.028 (+3.5%)

Close on Oct 19, 2026

Past 3 months -35.1% · daily closes, Jul 6, 2026 – Oct 19, 2026, adjusted for splits
Day range
$0.800 – $0.840 USDOct 19, 2026
Volume
155,956 sharesOct 19, 2026
Market cap
$30.67M USDAt the close on Oct 19, 2026 · price × 37.78M shares outstanding
Metagenomi Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:MGX · Home$0.812 USD+0.028 (+3.5%)155,956$0.800$0.840$0.800$0.784Close on Oct 19, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:MGX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.812+0.028+3.5%$0.800$0.840$0.800155,956
$0.784-0.061-7.2%$0.843$0.860$0.769163,663
$0.845-0.016-1.9%$0.861$0.880$0.835291,419
$0.861-0.056-6.1%$0.895$0.950$0.860293,525
$0.917-0.103-10.1%$1.020$1.030$0.910265,784
$1.020+0.020+2.0%$0.997$1.060$0.990150,973
$1.000+0.007+0.7%$0.990$1.040$0.990147,176
$0.993+0.008+0.9%$1.000$1.010$0.960354,862
$0.985-0.045-4.4%$1.010$1.020$0.960270,311
$1.030-0.010-1.0%$1.070$1.080$1.025121,027
$1.040+0.020+2.0%$1.010$1.060$1.010163,204
$1.020-0.085-7.7%$1.090$1.095$1.015121,953
$1.105+0.045+4.2%$1.060$1.110$1.060118,332
$1.060-0.070-6.2%$1.130$1.135$1.060152,289
$1.130-0.010-0.9%$1.130$1.149$1.10356,684
$1.140-0.010-0.9%$1.130$1.160$1.130135,965
$1.1500.0000.0%$1.140$1.165$1.14070,806
$1.150+0.020+1.8%$1.120$1.165$1.120211,649
$1.130-0.010-0.9%$1.140$1.145$1.120100,337
$1.140+0.020+1.8%$1.070$1.160$1.070165,230
$1.120+0.020+1.8%$1.110$1.140$1.092103,274
$1.100-0.030-2.7%$1.120$1.140$1.100124,384
$1.130-0.020-1.7%$1.150$1.165$1.130100,821
$1.150-0.010-0.9%$1.160$1.175$1.150111,001
$1.160-0.030-2.5%$1.190$1.190$1.150160,368
$1.190+0.030+2.6%$1.170$1.195$1.170157,856
$1.1600.0000.0%$1.160$1.220$1.16054,298
$1.160+0.010+0.9%$1.150$1.215$1.150471,785
$1.150-0.010-0.9%$1.170$1.200$1.150147,563
$1.160-0.010-0.9%$1.150$1.180$1.130293,707
$1.170+0.010+0.9%$1.140$1.170$1.14054,805
$1.1600.0000.0%$1.203$1.210$1.15069,013
$1.160-0.010-0.9%$1.160$1.190$1.150313,106
$1.170-0.010-0.8%$1.190$1.190$1.128239,768
$1.180-0.010-0.8%$1.180$1.190$1.170106,861
$1.190-0.020-1.7%$1.200$1.240$1.19078,134
$1.210-0.010-0.8%$1.230$1.230$1.20072,665
$1.220+0.010+0.8%$1.210$1.240$1.21059,572
$1.2100.0000.0%$1.220$1.250$1.210124,878
$1.210-0.020-1.6%$1.250$1.250$1.205211,237
$1.230+0.030+2.5%$1.220$1.260$1.200303,195
$1.200-0.040-3.2%$1.210$1.250$1.200107,016
$1.240+0.030+2.5%$1.210$1.250$1.210248,133
$1.210-0.010-0.8%$1.230$1.240$1.20466,485
$1.220-0.010-0.8%$1.230$1.240$1.215119,436
$1.2300.0000.0%$1.220$1.240$1.20083,500
$1.230+0.010+0.8%$1.210$1.250$1.210267,293
$1.220+0.010+0.8%$1.210$1.220$1.19591,289
$1.210-0.020-1.6%$1.180$1.246$1.180133,112
$1.2300.0000.0%$1.230$1.240$1.210151,591
$1.230-0.010-0.8%$1.240$1.248$1.225142,971
$1.240+0.025+2.1%$1.220$1.240$1.213146,314
$1.215+0.005+0.4%$1.220$1.225$1.20177,216
$1.2100.0000.0%$1.200$1.230$1.200110,955
$1.210+0.020+1.7%$1.190$1.240$1.190134,048
$1.190-0.030-2.5%$1.210$1.220$1.185135,772
$1.220+0.010+0.8%$1.200$1.230$1.200132,803
$1.2100.0000.0%$1.210$1.215$1.20035,452
$1.2100.0000.0%$1.210$1.230$1.200111,093
$1.210+0.005+0.4%$1.210$1.235$1.20068,242
$1.205-0.015-1.2%$1.240$1.240$1.20065,895
$1.220-0.020-1.6%$1.230$1.230$1.21052,381
$1.240+0.020+1.6%$1.300$1.300$1.200534,207
$1.2200.0000.0%$1.220$1.235$1.200189,106
$1.220-0.020-1.6%$1.240$1.265$1.200170,422
Ticker
NASDAQ:MGX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Metagenomi Therapeutics (NASDAQ:MGX) Q3 2025 Earnings Call

    Tue, Nov 11, 2025 · 4:30 PM ET

    Watch Transcript

Latest news

Metagenomi Therapeutics, Inc. to Participate in the Chardan 10th Annual Healthcare Conference

Oct 13, 2026

Closed $0.917 (-10.1%) on Oct 13, 2026

Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference

Sep 1, 2026

Closed $1.17 (-0.8%) on Sep 1, 2026

Metagenomi Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results

Aug 10, 2026

Closed $1.21 (-1.6%) on Aug 11, 2026

Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference

May 28, 2026

Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results

May 11, 2026

Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency

Apr 16, 2026

Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results

Mar 5, 2026

Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference

Feb 23, 2026

Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook

Jan 12, 2026

Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference

Dec 1, 2025

All Metagenomi Therapeutics, Inc. news

Decks

Metagenomi Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
13 in the last 12 months · 30 in all · newest Oct 13, 2026 · oldest 2024
Calls
1 call with a replay · 1 with a transcript · latest Nov 11, 2025
Decks
11 decks · latest Sep 22, 2026

Where Metagenomi Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:MGX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:MGXBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Metagenomi Therapeutics, Inc.